Ruchi PhD serves as the Alliance Director in Business Development & Licensing at Merck, where she plays a pivotal role in driving strategic partnerships and managing complex transactions that enhance the company's portfolio. With a robust background in pharmaceutical research and drug development, Ruchi leverages...
Ruchi PhD serves as the Alliance Director in Business Development & Licensing at Merck, where she plays a pivotal role in driving strategic partnerships and managing complex transactions that enhance the company's portfolio. With a robust background in pharmaceutical research and drug development, Ruchi leverages her expertise in project portfolio management to streamline processes and ensure that key initiatives align with Merck's strategic goals. Her unique perspective on the industry, honed through managing global alliances, allows her to navigate the intricacies of collaboration with Contract Research Organizations (CROs) and other stakeholders effectively.
Currently, Ruchi is spearheading several key projects aimed at advancing drug formulation and improving quality by design (QbD) methodologies. She is instrumental in conducting thorough due diligence on potential partnerships, ensuring that each collaboration is strategically sound and poised for success. Her adeptness in HPLC and pharmaceutics not only enhances the technical rigor of her projects but also fosters innovation in consumer healthcare solutions.
Ruchi's leadership in the Transaction Management Office has been critical in operationalizing initiatives that transform business performance. By focusing on the entire lifecycle of drug development—from early-stage research to market launch—she ensures that Merck remains at the forefront of the pharmaceutical industry. Her commitment to delivering solutions that improve operational efficiency and drive strategic outcomes underscores her reputation as a transformative leader in the field.
